Skip to main content

Want a detailed portfolio tracker?

RenovoRx (RNXT) P/E (2021 - 2026)

RenovoRx (RNXT) P/E from Aug 26, 2021 to Jul 21, 2026. The TTM RenovoRx (RNXT) P/E is -2.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of RenovoRx (RNXT)

YearP/EChange
2026-2.77+0.53%
2025-2.76-17.42%
2024-3.34+37.76%
2023-2.42+15.15%
2022-2.10-33.97%
2021-3.19N/A

Comparison RenovoRx (RNXT) P/E with competitors

RenovoRx (RNXT) P/E is -2.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.16%
ENLVEnlivex Ltd0.07-102.70%
FGENFibroGen Inc0.24-108.66%
CHRSCoherus Biosciences Inc0.85-130.62%
FBIOFortress Biotech Inc0.95-134.25%
ORMPOramed Pharmaceuticals Inc1.50-154.24%
AGENAgenus Inc3.01-208.60%
INVAInnoviva Inc3.15-213.81%
VXRTVaxart Inc3.55-228.09%
CRMDCorMedix Inc3.63-230.93%
CVACCureVac N.V.4.45-260.42%
GLPGGalapagos NV4.86-275.33%
SRPTSarepta Therapeutics Inc4.88-276.17%
ABEOAbeona Therapeutics Inc5.39-294.41%
ABUSArbutus Biopharma Corp5.60-301.92%
ZVRAZevra Therapeutics Inc5.89-312.44%
SPROSpero Therapeutics Inc6.23-324.75%
CGENCompugen Ltd6.31-327.84%
RIGLRigel Pharmaceuticals6.87-347.98%
SLXNSilexion Therapeutics Corp7.30-363.28%
OMEROmeros Corporation9.26-434.10%
AUPHAurinia Pharmaceuticals Inc9.58-445.87%
PLXProtalix BioTherapeutics Inc10.89-493.00%
ACADAcadia Pharmaceuticals Inc11.73-523.22%
TBPHTheravance Biopharma Inc12.26-542.48%
ADMAAdma Biologics Inc12.42-548.11%
HRMYHarmony Biosciences Holdings Inc13.82-598.70%
SABSSAB Biotherapeutics Inc14.14-610.10%
NAGENiagen Bioscience Inc14.82-634.71%
INCYIncyte Corp15.82-670.95%
REGNRegeneron Pharmaceuticals Inc15.86-672.18%
PBYIPuma Biotechnology Inc17.32-724.83%
CPRXCatalyst Pharmaceuticals Inc17.44-729.29%
EXELExelixis Inc17.54-732.85%
TGTXTG Therapeutics Inc18.97-784.39%
MDXGMimedx Group Inc20.55-841.63%
XOMAXOMA Royalty Corp22.87-925.45%
ARGXArgen X SE24.30-976.81%
CTMXCytomX Therapeutics Inc24.82-995.69%
XOMAOXOMA Royalty Corp25.34-1014.59%
HALOHalozyme Therapeutics Inc25.62-1024.65%
XOMAPXOMA Royalty Corp25.67-1026.32%
VRTXVertex Pharmaceuticals Inc27.99-1110.21%
RPRXRoyalty Pharma plc - Class A28.69-1135.21%
SLNOSoleno Therapeutics Inc29.02-1147.04%
ASNDAscendis Pharma A/S30.09-1185.66%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1468.08%
APLSApellis Pharmaceuticals Inc39.02-1508.11%
BMRNBiomarin Pharmaceutical Inc42.21-1623.24%
KRYSKrystal Biotech Inc45.34-1736.25%
ONCBeiGene Ltd69.54-2609.42%
PHARPharming Group N.V.75.03-2807.35%
TECHBio-Techne Corp101.96-3779.24%
VCELVericel Corp109.92-4066.59%
ALNYAlnylam Pharmaceuticals Inc117.96-4356.86%
GMABGenmab140.29-5162.50%
TLXTelix Pharmaceuticals Ltd162.15-5951.40%
CORTCorcept Therapeutics Inc212.86-7781.12%